We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · January 23, 2021

IVIg Therapy in Adults With Idiopathic Chronic Cardiomyopathy and Cardiac Parvovirus B19 Persistence

European Journal of Heart Failure

 

Additional Info

European Journal of Heart Failure
Intravenous Immunoglobulin Therapy in Adult Patients With Idiopathic Chronic Cardiomyopathy and Cardiac Parvovirus B19 Persistence: A Prospective, Double-Blind, Randomized, Placebo-Controlled Clinical Trial
Eur. J. Heart Fail 2020 Dec 21;[EPub Ahead of Print], MR Hazebroek, MTHM Henkens, AG Raafs, JAJ Verdonschot, JJ Merken, RM Dennert, C Eurlings, MA Abdul Hamid, PFG Wolffs, B Winkens, HP Brunner-La Rocca, C Knackstedt, P van Paassen, VPM van Empel, SRB Heymans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading